Florida Cannabis Retail Market Update, October 2026
Florida’s medical marijuana licenses are the headline this October 2026 after the Department of Health closed the April 2023 application cycle and granted 22 new vertically integrated permits. Within 10 business days of licensure, the 22 newly licensed MMTCs must post $5 million in financial assurance, and they face a staggered set of authorization clocks. A major Curaleaf tender offer for Aurora, proposed OMMU marketing rules, and a new Curaleaf store round out a busy month.
Top Headlines This Month
- ⚖️ Health Department grants 22 new medical marijuana licenses
- 💼 Curaleaf urges Aurora shareholders to accept $4 offer
- ⚖️ OMMU proposes ban on celebrity marijuana endorsements
- 🛒 Curaleaf opens 77th Florida Dispensary in Tampa Bay Area
⚖️ FLORIDA: HEALTH DEPARTMENT GRANTS 22 NEW MEDICAL MARIJUANA LICENSES
On September 11, 2026, the Florida Department of Health announced its Final Order, officially closing the April 2023 Medical Marijuana Treatment Center (MMTC) application process and granting 22 new vertically integrated licenses. More than 70 applicants had submitted comprehensive MMTC applications to the Department’s Office of Medical Marijuana Use in 2023, hoping to win one of these licenses. The Final Order awarded the licenses to the original winners selected during comparative scoring. This action counts as the Final Agency Action, so it starts the clock on a set of compliance deadlines the new licensees must meet to keep their awards in good standing.
The timeline moves fast for the 22 new licensees. Within 10 business days of licensure, by September 25, 2026, each must post $5 million in financial assurance through a surety bond, an irrevocable letter of credit, or cash with the Department’s Agency Clerk. From there, each has 180 calendar days to request cultivation authorization, 270 days to request processing authorization, and 365 days to request dispensing authorization. Any party adversely affected by the Final Order has 30 days from entry to seek judicial review with Florida’s First District Court of Appeal under Section 120.68, so the awards sit alongside a window for legal challenge even as the compliance clock runs.
Florida cannabis market dynamics are being closely watched as these new MMTCs ramp up toward full, vertical compliance within aggressive deadlines.
💼 NATIONAL: CURALEAF URGES AURORA SHAREHOLDERS TO ACCEPT $4 PER SHARE OFFER
Curaleaf Holdings sent a letter to Aurora Cannabis shareholders on September 15, 2026, pressing them to accept its pending cash and stock tender offer. The terms give each Aurora share 0.3463 Curaleaf shares plus US$0.75 in cash, which Curaleaf says implies a value of US$4.00 per share and a 45% premium over Aurora’s 30 day volume weighted average price of US$2.76 as of August 10, 2026. Shareholders must tender by December 1, 2026 to participate. Curaleaf states that a combined company would span operations in 17 countries, with more than US$1.5 billion of last twelve month revenue and nearly US$350 million of adjusted EBITDA for the period ended June 30, 2026, plus at least US$40 million in expected annual cost synergies. Curaleaf, led by Chairman and CEO Boris Jordan, also scheduled a shareholder Q&A webcast for September 17, 2026. The company’s own materials note that the September 15 communication is not itself the offer, which is made through the earlier Offer to Purchase and Circular.
The filing is a shareholder communication, not a completed deal, and it remains subject to the offer conditions and regulatory approvals that have not been resolved. Curaleaf frames its case partly on Aurora’s recent performance, citing that over the four quarters ended June 30, 2026, Aurora’s net revenue declined 14% and adjusted EBITDA declined 78%, with operating cash flow going negative. A combination of two publicly traded cannabis companies of this size would consolidate supply and retail reach across multiple countries if the tender closes.
Cannabis market mergers and acquisitions at this scale could reshape the retail and supply dynamics for multi-state and international operators.
⚖️ FLORIDA: OMMU PROPOSES RULES BANNING CELEBRITY ENDORSEMENTS FOR MEDICAL MARIJUANA
The Florida Office of Medical Marijuana Use proposed new marketing rules late last month that would ban the use of celebrities to endorse products, going further than the emergency restrictions that were finalized last year and later repealed. The proposals target celebrity backed items such as ear shaped gummies tied to Mike Tyson that were briefly sold at MÜV dispensaries operated by the Chicago based Verano, and strains such as Khalifa Kush, which Trulieve launched with rapper Wiz Khalifa. The rules also keep strict limits on the educational literature a dispensary can hand out and on images depicting people enjoying the effects of marijuana. The restrictions arrive as the state’s medical marijuana industry, valued at more than $2 billion, shows signs of decline. There are currently 28 state licensed medical companies operating 778 dispensaries across Florida, and some firms have been unable to pay renewal fees that now exceed $1 million on time. Gov. Ron DeSantis increased licensing renewal fees by more than 2,000 percent before campaigning against a 2024 recreational legalization ballot initiative that failed to pass. Surterra, one of the first companies licensed to sell and grow medical marijuana in the state, recently closed two growing facilities and laid off more than 100 workers.
Joe Puglise, CEO of the newly licensed Fino Cannabis, said the limits would make attracting new patients nearly impossible for startups that lack years to build out operations. Many treatment centers hired Tallahassee lawyer John Lockwood, who has filed a request for a public meeting and signaled a possible legal challenge if the rules are finalized without changes. It remains unclear whether the two candidates vying to replace DeSantis in November, Republican Rep. Byron Donalds and Democrat David Jolly, would ease the pressure on the industry.
These Florida cannabis marketing rules would represent some of the toughest in the country if adopted as proposed.
🛒 NEW STORE: CURALEAF OPENS 77TH FLORIDA DISPENSARY IN THE TAMPA BAY AREA
Curaleaf opened a new dispensary at 10422 US Hwy 301 S in Riverview, Florida, bringing its Florida retail count to 77 dispensaries and its nationwide total to 178 locations. A grand opening celebration took place September 18 and 19, 2026, with brand activations, in-store promotions, and giveaways. The store is located in a Tampa Bay area suburb with access to Tampa, Brandon, Apollo Beach, and the broader South Shore area. It carries Florida-exclusive Reef flower, Dark Heart ultra-premium flower, FIND flower, Anthem pre-rolls, and the Select Briq 2 all-in-one vape for medical patients.
Chairman and CEO Boris Jordan said the Riverview location is the latest of several openings Curaleaf has made in Florida since the beginning of the year. The dispensary operates Monday through Saturday from 9:00 A.M. to 8:30 P.M. ET and Sundays from 10:00 A.M. to 7:00 P.M. ET. Riverview has grown from a rural community along the Alafia River into what the company describes as a hub for young professionals and businesses, giving the new location reach across multiple communities in the South Shore region.
The Bottom Line
Florida’s medical marijuana market set the tone for October 2026 with 22 new licenses issued and a tight run of compliance deadlines now underway. Curaleaf pressed its $4 per share tender offer for Aurora. OMMU’s proposed marketing rules would ban celebrity endorsements as the state’s $2 billion medical program shows signs of strain, and new stores advancing with Curaleafs 77th Florida store opening.
📬 Get Monthly Market Updates
Stay ahead of the curve with our monthly cannabis retail market newsletter. New markets, regulatory changes, and expansion opportunities delivered to your inbox.
